Home > Insider Trading > Filing (0001593968-21-001513)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1397702	Silk Road Medical Inc	SILK	Surgical & Medical Instruments & Apparatus (3841)	208777622

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770191	S. Andrew Davis	C/O Silk Road Medical, Inc. 1213 Innsbruck Drive Sunnyvale CA 94089	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-01	1,657	$1.60	32,897	No	4	M	Direct
Common Stock	Disposition	2021-06-01	1,657	$47.23	31,240	No	4	S	Direct
Common Stock	Acquisiton	2021-06-01	4,667	$4.73	35,907	No	4	M	Direct
Common Stock	Disposition	2021-06-01	4,667	$47.23	31,240	No	4	S	Direct
Common Stock	Acquisiton	2021-05-20	420	$40.38	31,660	No	5	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	5	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2021-06-01	1,657	$0.00	1,657	$1.60
Common Stock	Option (right to buy)	Disposition	2021-06-01	4,667	$0.00	4,667	$4.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,475	2016-01-03	2025-12-03	No	4	M	Direct
79,592	2017-09-01	2027-11-30	No	4	M	Direct

Footnotes

The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
This transaction was executed in multiple trades at price ranging from $46.67 to $48.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
All of the shares subject to this option are fully vested and exercisable as of the date hereof.
One forty-eighth of the shares subject to the option shall vest on September 1, 2017 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.